Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
fda
4
×
life sciences
national blog main
san diego blog main
4
×
clinical trials
indiana blog main
new york blog main
raleigh-durham blog main
san diego top stories
san francisco blog main
seattle blog main
boston
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana top stories
investing
ipo
medical device
messenger rna
national
national top stories
new york top stories
nonalcoholic steatohepatitis
raleigh-durham top stories
san francisco top stories
seattle top stories
texas blog main
texas top stories
vc
venture capital
wisconsin blog main
wisconsin top stories
2025
ad-comm
affimed
What
million
4
×
ipo
therapeutics
developing
new
raised
allogene
beta
bio
bionics
biotechs
blood
brings
cancer
closed
club
companies
company
continued
crispr
crop
device
diabetes
disorders
diversity
driven
drug
dyne
dyne’s
exceeded
firms
genetic
group
haul
heads
hot
immunotherapy
investors
joined
juno
Language
unset
Current search:
million
×
fda
×
" san diego blog main "
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M